tiprankstipranks
pc:tther

T-Therapeutics

T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge. The company was created to harness the power of T cell biology, to create safe and effective treatments for cancer and autoimmune disease. T-Therapeutics is developing a pipeline of first-in-class drugs that are intended to become transformative medicines, reshaping the clinical landscape for patients with cancer or autoimmune diseases.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$91M
Total Amount Raised$91M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$91M
Latest Funding Amount$91M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 13, 2025
Series A
$91.00M

Investors

Investor Name
Funding Round

Related News and Analysis